Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-28

FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

The FDA approved Bayer HealthCare LLC's supplemental application for Claritin Allergy (loratadine). This action covers changes related to the product's labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin Allergy (Loratadine)

Snippet

SUPPL AP for CLARITIN ALLERGY (LORATADINE)